Edition:
India

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

393.00GBp
15 Dec 2017
Change (% chg)

3.20 (+0.82%)
Prev Close
389.80
Open
387.70
Day's High
393.00
Day's Low
385.50
Volume
2,414,750
Avg. Vol
3,036,861
52-wk High
421.50
52-wk Low
246.50

Chart for

About

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue... (more)

Overall

Beta: --
Market Cap(Mil.): £2,498.61
Shares Outstanding(Mil.): 721.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Indivior Announces NDA Acceptance Of RBP-7000 Risperidone Monthly Depot

* INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT

12 Dec 2017

U.S. FDA accepts application for Indivior's new schizophrenia drug

U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

12 Dec 2017

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

12 Dec 2017

BRIEF-‍Indivior Says FDA Accepts Application For New Schizophrenia Drug

* ‍INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT​

12 Dec 2017

LPC-Indivior launches US$485m-equiv loan refi

LONDON, Dec 5 Pharmaceuticals company Indivior has launched a US$485m-equivalent loan to refinance existing debt, banking sources said.

05 Dec 2017

Indivior drug to fight opioid addiction approved by U.S. FDA

Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product.

02 Dec 2017

UPDATE 1-FTSE falls in broad risk-off move as Trump worries resurface

* Indivior gains on US FDA drug approval (Recasts, adds details, closing prices)

01 Dec 2017

UK's Indivior posts profit in third quarter as costs fall

British drugmaker Indivior on Thursday reported a quarterly profit compared with a year-ago loss, as it benefited from lower costs.

02 Nov 2017

UPDATE 1-UK's Indivior posts profit in 3rd quarter as costs fall

Nov 2 British drugmaker Indivior on Thursday reported a quarterly profit compared with a year-ago loss, as it benefited from lower costs.

02 Nov 2017

UK's Indivior posts profit compared with year-ago loss

Nov 2 British drugmaker Indivior posted a quarterly profit compared with a year-ago loss, helped by strength in its U.S. business and lower costs.

02 Nov 2017

Earnings vs. Estimates